Private banking group J. Safra Sarasin has acquired 100 per cent of the shares of MIV Asset Management AG for an undisclosed amount.

The banking group stated that the acquisition highlighted its commitment to growth in asset management with its thematic equity investing capabilities.

MIV specialises in medical technology investments and is known for its flagship MIV Global Medtech Fund.

Upon completion of the deal, MIV will maintain its existing investment strategy and organisational structure.

Bank J. Safra Sarasin said MIV was well known for its “innovative approach and deep sector knowledge”, which would make it a “valuable addition” to its portfolio of thematic equity strategies.

It added that, with the medical technology sector set to grow amid an aging population, technological innovation, and increasing access in emerging markets, there are opportunities that make it a compelling long-term investment case for investors.

Commenting on the acquisition, Bank J. Safra Sarasin head of asset management & institutional clients division, Oliver Cartade, “We are thrilled to welcome MIV Asset Management into the J. Safra Sarasin Group.

“This acquisition aligns perfectly with our strategic vision to strengthen our thematic equity offerings and underscores our commitment to providing clients with unparalleled investment opportunities.

“MIV's exceptional team and proven track record will be instrumental in driving our growth and innovation in the thematic investing space.”

MIV Asset Management senior portfolio manager and CEO, Christoph Gubler, added: “We are excited to become part of the J. Safra Sarasin Group to ensure the long-term success of our investment strategy in the best interest of investors.

“We look forward to continuing our success story as part of the J. Safra Sarasin Group.”

---